Expression of interleukin-15 and interleukin-15rα in monocytes of HIV type 1-infected patients with different courses of disease progression

AIDS Research and Human Retroviruses

Volumn 28, Issue 7, 2012, Pages 693-701

  Tarkowski, MacIej ^a   Ferraris, Laurenzia ^a   Martone, Sara ^a   Strambio De Castillia, Francesco ^a   Misciagna, Donatella ^a   Mazzucchelli, Renata I ^b   Lattuada, Emanuela ^c   Paraninfo, Giuseppe ^d   Galli, Massimo ^a   Riva, Agostino ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b SAN RAFFAELE SCIENTIFIC INSTITUTE   (Italy)

^c POLICLINICO BORGO ROMA   (Italy)

^d SPEDALI CIVILI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; GAMMA INTERFERON;

ADULT; ARTICLE; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; GENE; GENE CONTROL; GENE EXPRESSION; GENE SYNTHESIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INTERLEUKIN 15 GENE; INTERLEUKIN 15 RECEPTOR ALPHA GENE; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL;

ADULT; AIDS VACCINES; ANTIGENS, CD14; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DISEASE PROGRESSION; FEMALE; FLOW CYTOMETRY; HIV SEROPOSITIVITY; HIV-1; HUMANS; INTERLEUKIN-15; INTERLEUKIN-15 RECEPTOR ALPHA SUBUNIT; MALE; MIDDLE AGED; MONOCYTES; PHENOTYPE;

EID: 84863219703     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2010.0317     Document Type: Article

References (51)

1. Langford SE, Ananworanich J, and Cooper DA: Predictors of disease progression in HIV infection: A review. AIDS Res Ther 2007;4:11.
2. Cotton MF, Ikle DN, Rapaport EL, Marschner S, Tseng PO, Kurrle R, and Finkel TH: Apoptosis of CD4 + and CD8+ T cells isolated immediately ex vivo correlates with disease severity in human immunodeficiency virus type 1 infection. Pediatr Res 1997;42:656-664. (Pubitemid 27459475)
3. Lewis DE, Tang DS, Adu-Oppong A, Schober W, and Rodgers JR: Anergy and apoptosis in CD8+ T cells from HIV-infected persons. J Immunol 1994;153:412-420. (Pubitemid 24186555)
4. Mueller YM, De Rosa SC, Hutton JA, Witek J, Roederer M, Altman JD, and Katsikis PD: Increased CD95/Fas-induced apoptosis of HIV-specific CD8( + ) T cells. Immunity 2001; 15:871-882. (Pubitemid 34075369)
5. Giorgi JV, Lyles RH, Matud JL, et al.: Predictive value of immunologic and virologic markers after long or short duration of HIV-1 infection. J Acquir Immune Defic Syndr 2002; 29:346-355. (Pubitemid 34288887)
6. Boyman O, Purton JF, Surh CD, Sprent J. Cytokines and Tcell homeostasis. Curr Opin Immunol 2007;19:320-6.
7. Margolick JB and Donnenberg AD: T-cell homeostasis in HIV-1 infection. Semin Immunol 1997;9:381-388. (Pubitemid 28021496)
8. Munier ML and Kelleher AD: Acutely dysregulated, chronically disabled by the enemy within: T-cell responses to HIV-1 infection. Immunol Cell Biol 2007;85:6-15. (Pubitemid 46067316)
9. Musso T, Calosso L, Zucca M, et al.: Human monocytes constitutively express membrane-bound, biologically active, and interferon-gamma-upregulated interleukin-15. Blood 1999;93:3531-3539. (Pubitemid 29220921)
10. Sato N, Patel HJ, Waldmann TA, and Tagaya Y: The IL-15/ IL-15Ralpha on cell surfaces enables sustained IL-15 activity and contributes to the long survival of CD8 memory T cells. Proc Natl Acad Sci USA 2007;104:588-593. (Pubitemid 46123069)
11. Olsen SK, Ota N, Kishishita S, et al.: Crystal structure of the interleukin-15 interleukin-15 Receptor alpha complex: Insights into trans and cis presentation. J Biol Chem 2007; 282(51):37191-37204.
12. Duitman EH, Orinska Z, Bulanova E, Paus R, and Bulfone- Paus S: How a cytokine is chaperoned through the secretory pathway by complexing with its own receptor: Lessons from interleukin-15 (IL-15)/IL-15 receptor alpha. Mol Cell Biol 2008;28:4851-4861.
13. Carson WE, Ross ME, Baiocchi RA, Marien MJ, Boiani N, Grabstein K, and Caligiuri MA: Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-gamma by natural killer cells in vitro. J Clin Invest 1995;96:2578-2582.
14. Flamand L, Stefanescu I, and Menezes J: Human herpesvirus- 6 enhances natural killer cell cytotoxicity via IL-15. J Clin Invest 1996;97:1373-1381. (Pubitemid 26098681)
15. Kennedy MK, Glaccum M, Brown SN, et al.: Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J Exp Med 2000;191:771-780.
16. Berard M, Brandt K, Bulfone-Paus S, and Tough DF: IL-15 promotes the survival of naive and memory phenotype CD8+ T cells. J Immunol 2003;170:5018-5026. (Pubitemid 36554732)
17. Mueller YM, Bojczuk PM, Halstead ES, Kim AH, Witek J, Altman JD, and Katsikis PD: IL-15 enhances survival and function of HIV-specific CD8+ T cells. Blood 2003;101:1024-1029. (Pubitemid 36139375)
18. White L, Krishnan S, Strbo N, Liu H, Kolber MA, Lichtenheld MG, Pahwa RN, and Pahwa S: Differential effects of IL- 21 and IL-15 on perforin expression, lysosomal degranulation, and proliferation in CD8 T cells of patients with human immunodeficiency virus-1 (HIV). Blood 2007;109:3873-3880. (Pubitemid 46641739)
19. Salhi Y and Costagliola D: Long-term nonprogression in HIV infection. Clinical Epidemiology Group from the Centre dInformation et de Soins de lImmunodeficience Humaine. J Acquir Immune Defic Syndr Hum Retrovirol 1997;16: 409-411.
20. Pantaleo G, Menzo S, Vaccarezza M, et al.: Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. N Engl J Med 1995;332:209-216.
21. Migueles SA, Sabbaghian MS, Shupert WL, et al.: HLA B 5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. Proc Natl Acad Sci USA 2000;97:2709-2714. (Pubitemid 30159236)
22. Migueles SA, Weeks KA, Nou E, et al.: Defective human immunodeficiency virus-specific CD8+ T-cell polyfunctionality, proliferation, and cytotoxicity are not restored by antiretroviral therapy. J Virol 2009;83:11876-11889.
23. Xin KQ, Hamajima K, Sasaki S, Tsuji T, Watabe S, Okada E, and Okuda K: IL-15 expression plasmid enhances cellmediated immunity induced by an HIV-1 DNA vaccine. Vaccine 1999;17:858-866. (Pubitemid 29074740)
24. Bolesta E, Kowalczyk A, Wierzbicki A, et al.: Increased level and longevity of protective immune responses induced by DNA vaccine expressing the HIV-1 Env glycoprotein when combined with IL-21 and IL-15 gene delivery. J Immunol 2006;177:177-191. (Pubitemid 43941648)
25. Calarota SA, Dai A, Trocio JN, Weiner DB, Lori F, and Lisziewicz J: IL-15 as memory T-cell adjuvant for topical HIV-1 DermaVir vaccine. Vaccine 2008;26:5188-5195.
26. Kutzler MA, Robinson TM, Chattergoon MA, et al.: Coimmunization with an optimized IL-15 plasmid results in enhanced function and longevity of CD8 T cells that are partially independent of CD4 T cell help. J Immunol 2005; 175:112-123. (Pubitemid 40884307)
27. Kraynyak KA, Kutzler MA, Cisper NJ, Laddy DJ, Morrow MP, Waldmann TA, and Weiner DB: Plasmid-encoded interleukin- 15 receptor alpha enhances specific immune responses induced by a DNA vaccine in vivo. Hum Gene Ther 2009;20:1143-1156.
28. Dubie RA, Maksaereekul S, Shacklett BL, et al.: Co-immunization with IL-15 enhances cellular immune responses induced by a vif-deleted simian immunodeficiency virus proviral DNA vaccine and confers partial protection against vaginal challenge with SIVmac251. Virology 2009;386:109-121.
29. Halwani R, Boyer JD, Yassine-Diab B, et al.: Therapeutic vaccination with simian immunodeficiency virus (SIV)- DNA+ IL-12 or IL-15 induces distinct CD8 memory subsets in SIV-infected macaques. J Immunol 2008;180:7969-7979.
30. Manrique M, Kozlowski PA, Wang SW, et al.: Nasal DNAMVA SIV vaccination provides more significant protection from progression to AIDS than a similar intramuscular vaccination. Mucosal Immunol 2009;2:536-550.
31. Li S, Qi X, Gao Y, Hao Y, Cui L, Ruan L, and He W: IL-15 increases the frequency of effector memory CD8 + T cells in rhesus monkeys immunized with HIV vaccine. Cell Mol Immunol 2010;7:491-494.
32. Yu H, Tawab-Amiri A, Dzutsev A, et al.: IL-15 ex vivo overcomes CD4+ T cell deficiency for the induction of human antigen-specific CD8+ T cell responses. J Leukoc Biol. 2011;90:205-214.
33. Pfaffl MW, Horgan GW, and Dempfle L: Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 2002;30:e36.
34. Resino S, Bellon JM, Gurbindo MD, and Munoz-Fernandez MA: CD38 expression in CD8+ T cells predicts virological failure in HIV type 1-infected children receiving antiretroviral therapy. Clin Infect Dis 2004;38:412-417. (Pubitemid 38200121)
35. Huntington ND, Legrand N, Alves NL, et al.: IL-15 transpresentation promotes human NK cell development and differentiation in vivo. J Exp Med 2009;206:25-34.
36. dEttorre G, Andreotti M, Carnevalini M, Andreoni C, Zaffiri L, Vullo V, Vella S, and Mastroianni CM: Interleukin-15 enhances the secretion of IFN-gamma and CC chemokines by natural killer cells from HIV viremic and aviremic patients. Immunol Lett 2006;103:192-195. (Pubitemid 43162935)
37. Haas DW, Geraghty DE, Andersen J, et al.: Immunogenetics of CD4 lymphocyte count recovery during antiretroviral therapy: An AIDS Clinical Trials Group study. J Infect Dis 2006;194:1098-10107.
38. Mueller YM, Makar V, Bojczuk PM, Witek J, and Katsikis PD: IL-15 enhances the function and inhibits CD95/Fas-induced apoptosis of human CD4 + and CD8 + effectormemory T cells. Int Immunol 2003;15:49-58. (Pubitemid 36163768)
39. Hryniewicz A, Price DA, Moniuszko M, et al.: Interleukin-15 but not interleukin-7 abrogates vaccine-induced decrease in virus level in simian immunodeficiency virus mac251- infected macaques. J Immunol 2007;178:3492-3504. (Pubitemid 46417614)
40. Mueller YM, Petrovas C, Bojczuk PM, et al.: Interleukin-15 increases effector memory CD8 + T cells and NK Cells in simian immunodeficiency virus-infected macaques. J Virol 2005;79:4877-4885. (Pubitemid 40464238)
41. Mueller YM, Do DH, Altork SR, et al.: IL-15 treatment during acute simian immunodeficiency virus (SIV) infection increases viral set point and accelerates disease progression despite the induction of stronger SIV-specific CD8 + T cell responses. J Immunol 2008;180:350-360.
42. Mortier E, Woo T, Advincula R, Gozalo S, and Ma A: IL- 15Ralpha chaperones IL-15 to stable dendritic cell membrane complexes that activate NK cells via trans presentation. J Exp Med 2008;205:1213-1225. (Pubitemid 351679694)
43. McInnes IB, Leung BP, Sturrock RD, Field M, and Liew FY: Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-alpha production in rheumatoid arthritis. Nat Med 1997;3:189-195. (Pubitemid 27064704)
44. Agostini C, Trentin L, Facco M, et al.: Role of IL-15, IL-2, and their receptors in the development of T cell alveolitis in pulmonary sarcoidosis. J Immunol 1996;157:910-918. (Pubitemid 26231399)
45. Di Sabatino A, Ciccocioppo R, Cupelli F, et al.: Epithelium derived interleukin 15 regulates intraepithelial lymphocyte Th1 cytokine production, cytotoxicity, and survival in coeliac disease. Gut 2006;55:469-477.
46. Betts MR, Nason MC, West SM, et al.: HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood 2006;107:4781-4789. (Pubitemid 43882629)
47. Migueles SA, Laborico AC, Shupert WL, et al.: HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nat Immunol 2002;3: 1061-1068. (Pubitemid 35363659)
48. Migueles SA, Osborne CM, Royce C, et al.: Lytic granule loading of CD8 + T cells is required for HIV-infected cell elimination associated with immune control. Immunity 2008;29:1009-1021.
49. Seder RA, Grabstein KH, Berzofsky JA, and McDyer JF: Cytokine interactions in human immunodeficiency virusinfected individuals: Roles of interleukin (IL)-2, IL-12, and IL-15. J Exp Med 1995;182:1067-1077.
50. Rook AH, Masur H, Lane HC, et al.: Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome. J Clin Invest 1983;72:398-403. (Pubitemid 13025882)
51. Juffroy O, Bugault F, Lambotte O, et al.: Dual mechanism of impairment of interleukin-7 (IL-7) responses in human immunodeficiency virus infection: Decreased IL-7 binding and abnormal activation of the JAK/STAT5 pathway. J Virol 2010;84:96-108.